News

As a disease that is best detected and treated early after onset, Alzheimer disease is characterized by a variety of aberrantly regulated proteins and molecules, which once identified can be used as biomarkers for disease and integrated into Alzheimer’s diagnostic tests. New research at the University of Illinois at Chicago by co-authors Dr.

Results from a recent study conducted by scientists at the Universidad Nacional Autónoma de México, Instituto Nacional de Pediatría, Centro Médico Cozumel Universities of Montana, Valle de México, Boise State and North Carolina, revealed that air pollution has a harmful effect on hippocampal metabolites as early neurodegeneration markers among young urbanites…

According to a new analysis conducted by Alzheimer’s Research UK one in three people born in 2015 will develop Alzheimer’s Disease (AD) during their lifetime. The results suggest an alarming crisis in national health as the population in the United Kingdom ages, and highlights the demand for global efforts to develop new successful…

Results from a recent study showed that women are more likely to not only be diagnosed with Alzheimer’s Disease (AD), but to also be more heavily burdened by the associated economic costs, compared to men.  The study, entitled, “Gender Differences: A Lifetime Analysis of the Economic Burden of…

Results from the largest nationwide study investigating long-term high-dose resveratrol in patients with mild to moderate Alzheimer’s disease (AD) showed that a specific a biomarker that declines with disease progression was stabilized in patients who received resveratrol in its purified form. The results, published online in Neurology,…